2017
DOI: 10.1186/s12866-017-1017-3
|View full text |Cite
|
Sign up to set email alerts
|

When more is less: Emergent suppressive interactions in three-drug combinations

Abstract: BackgroundIn drug-drug interactions, there are surprising cases in which the growth inhibition of bacteria by a single antibiotic decreases when a second antibiotic is added. These interactions are termed suppressive and have been argued to have the potential to limit the evolution of resistance. Nevertheless, little attention has been given to suppressive interactions because clinical studies typically search for increases in killing efficiency and because suppressive interactions are believed to be rare base… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
38
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
7
2
1

Relationship

3
7

Authors

Journals

citations
Cited by 31 publications
(42 citation statements)
references
References 47 publications
2
38
0
Order By: Relevance
“…Finally, we note that we identified interactions as ‘inconclusive’ when the normalisation factor ||wfalse~XY-wXwY was equal to zero, consistent with previous studies (e.g. Beppler et al 2017).…”
Section: Methodssupporting
confidence: 91%
“…Finally, we note that we identified interactions as ‘inconclusive’ when the normalisation factor ||wfalse~XY-wXwY was equal to zero, consistent with previous studies (e.g. Beppler et al 2017).…”
Section: Methodssupporting
confidence: 91%
“…After conducting careful dose-dependence tests in vitro , the next key step in translating suppressive combinations to the clinic would be testing suppressive combinations in animal models to establish better understanding of risks as well as necessary concentrations, pharmacodynamics, and pharmacokinetics. 107 These tests would also help us understand how quickly resistance profiles of bacterial populations change in response to suppressive drugs in vivo. This would in turn inform the timing of switches from suppressive to synergistic or classic antibiotic treatment once most of the resistant bacteria have been killed.…”
Section: Future Directionsmentioning
confidence: 99%
“…The consequences of the accumulation of these short chain fatty acids and other small molecules on microenvironments, as well as their effect on bacterial physiology and antibiotic treatment efficacy in vivo , have yet to be systematically explored. Our results emphasize the need to probe the action of antibiotics – as well as other drugs that are thought not to target microbial growth 45 – in complex and varied conditions 46 . Furthermore, our findings highlight the utility of studying growth physiology in co-cultures in the absence of antibiotics for uncovering novel mechanisms of community-encoded protection against antibiotics.…”
Section: Discussionmentioning
confidence: 76%